Christopher Welberry
Chris is currently a Senior Scientist at Oncimmune working on the design and development of Oncimmune’s product portfolio.
He completed a PhD at the University of Nottingham entitled “Development and validation of an autoantibody-based blood test for hepatocellular carcinoma”. This provided part of the development of Oncimmune’s EarlyCDT Liver blood test for the detection of hepatocellular carcinoma. Chris will be acting as Oncimmune's project manager for DeLIVER.
